CN Stock MarketDetailed Quotes

603538 Ningbo Menovo Pharmaceutical

Watchlist

12.76
+0.46+3.74%

Market Closed Jan 17 15:00 CST

2.79BMarket Cap137.20P/E (TTM)

Ningbo Menovo Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ningbo Menovo Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.870B	--
--	2024/FY	-- / 1.481B	--
--	2023/FY	1.216B / 1.495B	--
--	2022/FY	1.457B / 1.695B	--
--	2021/FY	1.258B / 1.233B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.870B--

--2024/FY-- / 1.481B--

--2023/FY1.216B / 1.495B--

--2022/FY1.457B / 1.695B--

--2021/FY1.258B / 1.233B--

Unlock Free Earnings Estimates

Open Account

Ningbo Menovo Pharmaceutical Earnings Reports

Ningbo Menova Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 29, 2024 12:00 ET

Ningbo Menova Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

Aug 30, 2024 12:00 ET

Summary of the 2024 semi-annual report of Ningbo Menova Pharmaceutical Co., Ltd.

Aug 30, 2024 12:00 ET

Ningbo Menova Pharmaceutical Co., Ltd. 2024 First Quarter Report

Apr 29, 2024 12:00 ET

Analyst Rating

Updated: Jan 18, 2025

Buy

Strong Buy
33.33%
Buy
66.67%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data